HCA Healthcare Inc.

HCA | NYSE

Price Alert Chart Builder DCF Calculator

$425.97

-$1.74 (-0.41%)

At close: Sep 21, 2026, 4:00 PM ET

$425.97

$0 (0.00%)

After-hours: Sep 21, 2026, 5:55 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $92.6B

Enterprise Value $139.99B

Beta 1.11

Average Volume 1.53M

Shares Outstanding (Diluted) 222.83M

Shares Change YoY -7.89%

Institutional Ownership 58.00%

Exchange NYSE

ISIN US40412C1018

Price Performance

Price Change 1M -1.6%

Price Change 3M 10.1%

Price Change 6M -12.0%

Price Change YTD -9.4%

Price Change 1Y 4.6%

Price Change 3Y 68.8%

Price Change 5Y 66.2%

1M CAGR (ann.) 4.8%

1Y CAGR (ann.) 7.8%

5Y CAGR (ann.) 11.7%

All-Time CAGR 20.7%

Valuation

PE Ratio 14.26

Forward PE 12.48

PEG Ratio 0.58

Forward PEG 1.63

PS Ratio 1.18

Forward PS 1.10

PB Ratio -14.03

P/FCF Ratio 15.38

P/Adj. FCF Ratio 15.38

P/OCF Ratio 8.53

EV/Sales 1.79

EV/EBIT 11.51

EV/EBITDA 8.84

EV/FCF 23.34

Earnings Yield 7.0%

FCF Yield 6.5%

Adj. FCF Yield 6.5%

Financial Health

Net Debt $45.95B

Total Debt $48.78B

Cash & Short-Term Investments $1.01B

Total Assets $60.53B

Current Ratio 0.78

Quick Ratio 0.69

Debt / Equity Ratio -7.42

Debt / EBITDA 3.08

Debt / FCF 8.13

OCF / Debt 0.23

Interest Coverage 5.21

Altman Z-Score 2.60

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 28.4%

Operating Profit Margin 15.5%

EBITDA Margin 20.3%

Net Profit Margin 8.8%

FCF Margin 7.7%

Adj. FCF Margin 7.7%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets 11.3%

Return on Equity -112.9%

Return on Invested Capital 19.4%

Return on Capital Employed 29.2%

Return on Tangible Assets 13.7%

Historical Growth (CAGR)

Revenue CAGR 3Y 8.0%

Revenue CAGR 5Y 6.8%

Revenue CAGR 10Y 6.7%

EPS CAGR 3Y 13.7%

EPS CAGR 5Y 15.4%

EPS CAGR 10Y 17.8%

FCF CAGR 3Y 6.7%

FCF CAGR 5Y 56.4%

FCF CAGR 10Y 7.7%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 46

EPS Growth Next 3Y 9.4%

Revenue Growth Next 3Y 5.3%

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value $460.60

Lynch Upside 8.1%

Price Target $455.19

Price Target Upside 6.9%

Cash Flow

Operating Cash Flow $11.12B

Free Cash Flow $6B

Adj. Free Cash Flow $6B

FCF Per Share $26.91

OCF Per Share $49.92

OCF/S Ratio 14.3%

Income Statement

Revenue $78.01B

Gross Profit $22.12B

Operating Income $12.07B

EBITDA $15.84B

Net Income $6.84B

EPS (Diluted) $29.87

Revenue / Employee $243.79K

Profit / Employee $21.38K

Employees 320,000

Dividends

Annual Dividend $3.06

Dividend Yield 0.72%

Payout Ratio 10.2%

FCF Payout Ratio 11.4%

Adj. FCF Payout Ratio 11.4%

Dividend Growth (YoY) 8.5%

Pay Frequency Quarterly

Ex-Dividend Date Sep 15, 2026